What is Osome?
Osome, headquartered in Singapore and launched in January 2017, is a comprehensive business management platform designed for small and medium-sized enterprises (SMEs). The company offers a suite of services including online accounting, business registration, corporate secretary functions, and payroll management. By leveraging automation tools and artificial intelligence, Osome aims to enhance response times, improve accuracy, and reduce operational costs for its clients. The company has established a market presence in Singapore, the United Kingdom, and Hong Kong, positioning itself as a key player in streamlining SME operations through technology.
How much funding has Osome raised?
Osome has raised a total of $64M across 5 funding rounds:
Other Financing Round
$3M
Other Financing Round
$3M
Series A
$16M
Other Financing Round
$25M
Series B
$17M
Other Financing Round (2019): $3M with participation from Phystech Venture, Adfirst, and Target Global
Other Financing Round (2020): $3M led by AltaIR Capital and XA Network
Series A (2021): $16M supported by AltaIR Capital, Target Global, S16VC, Phystech Ventures, and Peng T. Ong
Other Financing Round (2022): $25M featuring AFG Partners, Illuminate Financial, and Winter Capital
Series B (2024): $17M, investors not publicly disclosed
Key Investors in Osome
AltaIR Capital
AltaIR Capital is an international early-stage venture investment company that focuses on backing promising startups with disruptive ideas across various sectors, including Productivity Tools, HR Tech, FinTech, InsurTech, and Digital Health.
Target Global
Since its founding in 2015, Target Global has established itself as a leading a pan-European technology investment firm with more than 3 billion in assets under management, investing in companies across all stages of their lifecycle, from pre-seed to pre-IPO.
Phystech Ventures
Phystech Ventures is a leading deeptech venture capital fund focused on supporting the next generation of scientific breakthroughs. The firm specializes in investing in deeptech startups that utilize fundamental scientific advancements to develop disruptive solutions.
What's next for Osome?
The recent major strategic investment in Osome signals a pivotal phase for the company, likely aimed at accelerating its expansion into new markets and further developing its AI-driven platform. This capital infusion is expected to bolster its competitive edge in the business management software landscape, enabling Osome to enhance its service offerings and scale its operations to meet the growing demand from SMEs seeking efficient and cost-effective solutions. The company's trajectory suggests a focus on deepening its technological capabilities and solidifying its position as a leader in automated business administration.
See full Osome company page
